FEATURED POST

A Most American Terrorist: The Making of Dylann Roof

Image
“What are you?” a member of the Mother Emanuel AME Church in Charleston asked at the trial of the white man who killed eight of her fellow black parishioners and their pastor. “What kind of subhuman miscreant could commit such evil?... What happened to you, Dylann?”
Rachel Kaadzi Ghansah spent months in South Carolina searching for an answer to those questions—speaking with Roof’s mother, father, friends, former teachers, and victims’ family members, all in an effort to unlock what went into creating one of the coldest killers of our time.
Sitting beside the church, drinking from a bottle of Smirnoff Ice, he thought he had to go in and shoot them.
They were a small prayer group—a rising-star preacher, an elderly minister, eight women, one young man, and a little girl. But to him, they were a problem. He believed that, as black Americans, they were raping “our women and are taking over our country.” So he took out his Glock handgun and calmly, while their eyes were closed in prayer, ope…

Dutch pharma firm reprimanded for drug used in U.S. executions

The Dutch branch of the Organization for Economic Cooperation and Development (OECD) reprimanded pharmaceutical company Mylan for doing to little to prevent their drugs being used in executions in the United States, the Volkskrant reports.

The OECD reprimanded Mylan at the insistence of death penalty lawyer Bart Staperd.

The pharmaceutical company now has to update its sales policy and make sure that their products are not used in executions. 

Mylan is originally an American company, but is established in the Netherlands for tax reasons. It therefore has to comply with Dutch human rights laws and provisions.

The drug involved is muscle relaxant rocuronium bromide. In the United States it is used as part of the cocktail given to death penalty prisoners at their execution.

Mylan initially defended itself by claiming that they do not always have control over the distribution of the drug. They sell rocuronium bromide wholesale to American hospitals, to be used for anesthesia in medical treatments. It is not directly supplied to prisons.

The OECD does not find that excuse acceptable, and instructed Mylan to better monitor the trade of the drug, even after they sold it. The company now promised to put more effort into monitoring where the drug ends up.

Source: nltimes.nl, April 12, 2016

- Report an error, an omission: deathpenaltynews@gmail.com - Follow us on Facebook and Twitter

Most Viewed (Last 7 Days)

Marcellus Williams faces execution in Missouri despite doubts about conviction

Vietnam upholds death sentences against shipping execs in major corruption case

Georgia executes Emmanuel Hammond

As Sammantha Allen Heads for Death Row, Will Arizona Execute a Woman Again?

Damien Echols says he suffered brain injuries on death row, his wife calls for end to executions

France condemns Iran execution of juvenile offender Alireza Tajiki

Florida set to conduct its first execution in a year and a half

Missouri governor stays execution of Marcellus Williams after attorneys say DNA evidence exonerates him

Most American Indian tribes opt out of federal death penalty

Johnson & Johnson unit speaks out at planned death row drug use